BOSTON, May 12, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today ...

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced first quarter 2025 financial results and provided a business update. "Our ...

Uncertainty around ELEVIDYS sales impact Sarepta Therapeutics, Inc. Click here to find out why I downgraded SRPT stock to a ...

Imperial College London researchers say they may have found a crucial ‘piece to the puzzle’ why asthma is worse for women and ...

Acute ischemic stroke is a leading global cause of death and disability. Intravenous thrombolysis was the first acute treatment developed for ischemic strokes. First with alteplase and now with ...

With Amperfied, HEIDELBERG aims to become one of the leading system providers of charging solutions for companies and public ...

With the election campaign now fading into the rear-view mirror, the parties, particularly the Liberals, will be reviewing ...

Our vision for the School is to be a global leader empowering individuals, organisations and societies to critically understand and inform a rapidly changing information, journalism and communication ...

"Innovative Technologies and Trends in AI, 3D Imaging, and Minimally Invasive Diagnostics Drive Growth in the Medical Imaging Market" BOSTON, May 6, 2025 /PRNewswire/ -- According to the ...

Fungal condition aspergillosis could be set to spread across Europe, Asia and America as a result of climate change, with ...